MarketAxess控股 MKTX 深 滬
等待開盤 08-13 09:30:00 美东时间
188.135
-1.135
-0.60%
華盛通- 最 高190.87
- 今 開189.27
- 成交量 35.77万股
- 最 低 186.32
- 昨 收 189.27
- 總市值 70.55亿
- 52周最高 294.42
- 市盈率 靜 25.85
- 換手率 0.95%
- 52周最低 182.995
- 委 比 -16.13%
- 總股本 3750.17万
- 歷史最高 593.65
- 量 比 0.36
- 振 幅 2.40%
- 歷史最低 0.04
- 每 手 1
- 風險率 25.38%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Beyond The Numbers: 6 Analysts Discuss MarketAxess Holdings Stock
In the preceding three months, 6 analysts have released ratings for MarketAxess...
08-12 02:01
BitMine, Lemonade, Sezzle, Kemper record biggest weekly swings in heat of earnings season
A flurry of corporate earnings reports helped shape this week's biggest movers across the financials sector. Overall, the Financial Select Sector SPDR ETF (XLF) edged up 0.9% in the week ended Aug. 8,...
08-09 22:10
美股大行评级 | DoorDash获上调目标价从230美元升至300美元； 摩根大通上调Shopify目标价从115美元升至179美元
今日重点评级关注：HC Wainwright & Co.：维持FibroGen"买入"评级，目标价从10美元升至43美元；摩根大通：维持Cogent Biosciences"超配"评级，目标价从29美元升至30美元
08-08 09:34
Barclays Maintains Equal-Weight on MarketAxess Holdings, Lowers Price Target to $200
Barclays analyst Benjamin Budish maintains MarketAxess Holdings (NASDAQ:MKTX) with a Equal-Weight and lowers the price target from $237 to $200.
08-07 21:33
MarketAxess Holdings shares are trading lower following the release of its Q2 financial results.
MarketAxess Holdings shares are trading lower following the release of its Q2 f...
08-06 23:34
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
MarketAxess Launches Mid-X In US Credit
Enhanced mid-point matching protocol launching in September for US IG and HY Bonds
08-05 20:42
Stocks most and least likely to beat their earnings expectations – BofA
Sectors with strong EPS/sales revision and guidance have been more likely to have a greater number of earnings beats than misses in the following earnings period, according to BofA analysts. “Given th...
07-15 02:03
美股大行评级 | 巴克莱上调 Robinhood目标价至102美元；瑞银下调京东目标价从58美元至50美元
今日重点评级关注：摩根大通：维持Cogent Biosciences"超配"评级，目标价从25美元升至29美元；摩根士丹利：维持Legend Biotech"超配"评级，目标价从80美元升至81美元
07-11 09:04
Expert Outlook: MarketAxess Holdings Through The Eyes Of 6 Analysts
In the preceding three months, 6 analysts have released ratings for MarketAxess...
07-11 05:00
